Jean‐Claude Chomel

Loss of Major Molecular Response As a Trigger for Restarting Tyrosine Kinase Inhibitor Therapy in Patients With Chronic-Phase Chronic Myelogenous Leukemia Who Have Stopped Imatinib After Durable Undetectable Disease

Philippe Rousselot, Aude Charbonnier, Pascale Cony‐Makhoul et al. · Journal of Clinical Oncology · 2013 · 405 citations · Full text

Modification of enzymatic-ally amplified DNA for the detection of point mutations

A. Haliassos, Jean‐Claude Chomel, Laurent Tesson et al. · Nucleic Acids Research · 1989 · 322 citations

Engineering, Genetics, Dna Analysis +17

Spectrum of CFTR mutations in cystic fibrosis and in congenital absence of the vas deferens in France

Mireille Claustres, Caroline Guittard, Dominique Bozon et al. · Human Mutation · 2000 · 250 citations

Leukemic stem cell persistence in chronic myeloid leukemia patients with sustained undetectable molecular residual disease

Jean‐Claude Chomel, Marie‐Laure Bonnet, Nathalie Sorel et al. · Blood · 2011 · 194 citations · Full text

Detection of minority point mutations by modified PCR technique: a new approach for a sensitive diagnosis of tumor-progression markers

A. Haliassos, Jean‐Claude Chomel, S Grandjouan et al. · Nucleic Acids Research · 1989 · 178 citations · Full text

Genetics, Dna Analysis, Pathology +24